Document Detail


Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarction.
MedLine Citation:
PMID:  11848437     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We recently identified a polymorphic Sp1 binding site in an enhancer at the tissue-type plasminogen activator (tPA) locus (tPA -7,351C/T), which was associated with vascular tPA release. Subjects homozygous for the -7,351C allele had twice the tPA release rate compared to subjects carrying the -7,351T allele. In this study we tested the hypothesis that the tPA -7,351C/T polymorphism is associated with myocardial infarction (MI). In a population-based prospective nested case-control study within northern Sweden, genotypes were determined among 61 MI cases and 120 controls. In a multivariate model, the tPA -7,351C/T polymorphism (OR 2.68 for T allele carriers; 95% CI 1.31-5.50), tPA antigen (OR 1.16; 95% CI 1.07-1.25) and apo A-I (OR, 0.997; 95% CI 0.995-0.999) were independently associated with a first MI. These findings suggest that genetic markers of local tPA release and circulating steady-state tPA levels carry independent prognostic information.
Authors:
Per Ladenvall; Lars Johansson; Jan-Håkan Jansson; Sverker Jern; Torbjörn K Nilsson; Anna Tjärnlund; Christina Jern; Kurt Boman
Related Documents :
8514147 - Mutations in pol1 increase the mitotic instability of tandem inverted repeats in saccha...
10192387 - An untranslated ctg expansion causes a novel form of spinocerebellar ataxia (sca8)
10942107 - Analysis of cag repeats in sca1, sca2, sca3, sca6, sca7 and drpla loci in spinocerebell...
1973377 - Structure and chromosomal mapping of a highly polymorphic repetitive dna sequence from ...
12700447 - Association between an interleukin-4 promoter polymorphism and the acquisition of cxcr4...
9657847 - An improved linkage map of rat chromosome 3 with three mapping panels.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  87     ISSN:  0340-6245     ISO Abbreviation:  Thromb. Haemost.     Publication Date:  2002 Jan 
Date Detail:
Created Date:  2002-02-18     Completed Date:  2002-08-27     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  105-9     Citation Subset:  IM    
Affiliation:
Cardiovascular Institute, Clinical Experimental Research Laboratory, Sahlgrenska University Hospital/Ostra, Göteborg University, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apolipoprotein A-I / analysis
Binding Sites
Cardiovascular Diseases / epidemiology
Case-Control Studies
Enhancer Elements, Genetic / genetics*
Female
Genetic Predisposition to Disease
Health Surveys
Humans
Hypertension / epidemiology
Intervention Studies
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction / epidemiology,  genetics*
Obesity / epidemiology
Odds Ratio
Plasminogen Activator Inhibitor 1 / analysis
Polymorphism, Genetic
Prognosis
Prospective Studies
Risk
Risk Factors
Sp1 Transcription Factor / metabolism
Sweden / epidemiology
Tissue Plasminogen Activator / genetics*,  secretion
Chemical
Reg. No./Substance:
0/Apolipoprotein A-I; 0/Plasminogen Activator Inhibitor 1; 0/Sp1 Transcription Factor; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Malignant fibrous histiocytoma of the kidney.
Next Document:  Enhancement of endogenous plasminogen activator-induced thrombolysis by argatroban and APC and its c...